BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Crespo J, Cuadrado A, Perelló C, Cabezas J, Llerena S, Llorca J, Cedillo S, Llop E, Escudero MD, Hernández Conde M, Puchades L, Redondo C, Fortea JI, Gil de Miguel A, Serra MA, Lazarus JV, Calleja JL. Epidemiology of hepatitis C virus infection in a country with universal access to direct-acting antiviral agents: Data for designing a cost-effective elimination policy in Spain. J Viral Hepat 2020;27:360-70. [PMID: 31755634 DOI: 10.1111/jvh.13238] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Guerra Veloz MF, Del Pino Bellido P, Cordero Ruiz P, Vega Rodriguez F, Bellido Muñoz F, Ramirez de Arellano E, Caunedo Álvarez A, Pascual Hernandez A, Carmona Soria I. HCV microelimination strategies: An interventional study in diagnosed patients without access to the system. Liver Int 2021;41:928-33. [PMID: 33587789 DOI: 10.1111/liv.14824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Cabezas J, Llerena S, Mateo M, Álvarez R, Cobo C, González V, Martró E, Cuadrado A, Crespo J. Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences. Diagnostics (Basel) 2021;11:877. [PMID: 34068955 DOI: 10.3390/diagnostics11050877] [Reference Citation Analysis]
3 Carty PG, Fawsitt CG, Gillespie P, Harrington P, O'Neill M, Smith SM, Teljeur C, Ryan M. Population-Based Testing for Undiagnosed Hepatitis C: A Systematic Review of Economic Evaluations. Appl Health Econ Health Policy 2021. [PMID: 34870793 DOI: 10.1007/s40258-021-00694-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Calleja JL, Rivera-Esteban J, Aller R, Hernández-Conde M, Abad J, Pericàs JM, Benito HG, Serra MA, Escudero A, Ampuero J, Lucena A, Sánchez Y, Arias-Loste MT, Iruzubieta P, Romero-Gómez M, Augustin S, Crespo J. Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology. Liver Int 2022. [PMID: 35643936 DOI: 10.1111/liv.15323] [Reference Citation Analysis]
5 Crespo J, Lázaro P, Blasco AJ, Aguilera A, García-Samaniego J, Eiros JM, Calleja JL, García F. Hepatitis C reflex testing in Spain in 2019: A story of success. Enferm Infecc Microbiol Clin (Engl Ed) 2021;39:119-26. [PMID: 32451150 DOI: 10.1016/j.eimc.2020.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
6 Erice A, Varillas-Delgado D, Caballero C. Prevalence and characteristics of hepatitis C virus infection detected by extended screening of working-age adults in Madrid (Spain). J Viral Hepat 2021. [PMID: 34224188 DOI: 10.1111/jvh.13564] [Reference Citation Analysis]
7 Cuadrado A, Perelló C, Cabezas J, Llerena S, Llop E, Escudero MD, Hernandez-Conde M, Puchades L, Redondo C, Fortea JI, Gil de Miguel A, Serra MA, Calleja JL, Crespo J. Update on epidemiology of hepatitis B in a low-endemic European country: There is still much to do. J Viral Hepat 2020;27:1261-5. [PMID: 32558971 DOI: 10.1111/jvh.13350] [Reference Citation Analysis]
8 Kondili LA, Gamkrelidze I, Blach S, Marcellusi A, Galli M, Petta S, Puoti M, Vella S, Razavi H, Craxi A, Mennini FS; PITER collaborating group. Optimization of hepatitis C virus screening strategies by birth cohort in Italy. Liver Int 2020;40:1545-55. [PMID: 32078234 DOI: 10.1111/liv.14408] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
9 Iruzubieta P, Fernández-Lanas T, Rasines L, Cayon L, Álvarez-Cancelo A, Santos-Laso A, García-Blanco A, Curiel-Olmo S, Cabezas J, Wallmann R, Fábrega E, Martínez-Taboada VM, Hernández JL, López-Hoyos M, Lazarus JV, Crespo J. Feasibility of large-scale population testing for SARS-CoV-2 detection by self-testing at home. Sci Rep 2021;11:9819. [PMID: 33972607 DOI: 10.1038/s41598-021-89236-x] [Reference Citation Analysis]
10 Liu CH, Su TH, Liu CJ, Chen PJ, Chen DS, Kao JH. Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan. J Formos Med Assoc 2020;119:1871-5. [PMID: 32553687 DOI: 10.1016/j.jfma.2020.06.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Gómez Camarero J, Badia Aranda E, Quiñones Castro R, Saiz Chumillas RM, Alcoba Vega L, Díez Ruiz S, Gómez Manero N, Vinuesa Campo R, Jorquera Plaza F. Hepatitis B and C screening in hospitalized patients with SARS-CoV-2 infection. Gastroenterol Hepatol 2021:S0210-5705(21)00250-8. [PMID: 34508809 DOI: 10.1016/j.gastrohep.2021.09.002] [Reference Citation Analysis]
12 Lazarus JV, Villota-rivas M, Fernández I, Gea F, Ryan P, López SA, Guy D, Calleja JL, García-samaniego J. A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid. Commun Med 2022;2. [DOI: 10.1038/s43856-022-00077-9] [Reference Citation Analysis]
13 Stasi C, Silvestri C, Voller F. Update on Hepatitis C Epidemiology: Unaware and Untreated Infected Population Could Be the Key to Elimination. SN Compr Clin Med. 2020;1-8. [PMID: 33103061 DOI: 10.1007/s42399-020-00588-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wang H, Liu X, Tan C, Zhou W, Jiang J, Peng W, Zhou X, Mo L, Chen L. Bacterial, viral, and fungal infection-related risk of Parkinson's disease: Meta-analysis of cohort and case-control studies. Brain Behav. 2020;10:e01549. [PMID: 32017453 DOI: 10.1002/brb3.1549] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
15 Estirado Gómez A, Justo Gil S, Limia A, Avellón A, Arce Arnáez A, González-Rubio R, Diaz A, Del Amo J; Working group of the HCV prevalence study in Spain in 2017–2018. Prevalence and undiagnosed fraction of hepatitis C infection in 2018 in Spain: results from a national population-based survey. Eur J Public Health 2021:ckab069. [PMID: 34392348 DOI: 10.1093/eurpub/ckab069] [Reference Citation Analysis]
16 Llop E, Iruzubieta P, Perelló C, Fernández Carrillo C, Cabezas J, Escudero MD, González M, Hernández Conde M, Puchades L, Arias-Loste MT, Serra MÁ, Crespo J, Calleja JL. High liver stiffness values by transient elastography related to metabolic syndrome and harmful alcohol use in a large Spanish cohort. United European Gastroenterol J 2021. [PMID: 34077628 DOI: 10.1002/ueg2.12109] [Reference Citation Analysis]
17 Crespo J, Lazarus JV, Iruzubieta P, García F, García-Samaniego J; Alliance for the Elimination of Viral Hepatitis in Spain. Let's leverage SARS-CoV2 vaccination to screen for hepatitis C in Spain, in Europe, around the world. J Hepatol 2021;75:224-6. [PMID: 33757805 DOI: 10.1016/j.jhep.2021.03.009] [Reference Citation Analysis]